Hugh Brady (academic)

Brady was born on 9 August 1959 in Dublin. ==Medical career==

From 1987 to 1996, Brady served sequentially as Fellow, instructor in medicine, assistant professor of medicine and associate professor of medicine at Harvard University, where he led his own research group and taught at Harvard Medical School. He was also Attending (consultant) Physician at the Brigham and Women's Hospital and director of nephrology at the Harvard-affiliated Brockton-West Roxbury VA Medical Centre. He was awarded research grants from the William H. Milton Fund, National Institutes of Health (NIDDK), National Kidney Foundation, USA and American Heart Association. In 1996, Brady was appointed professor of medicine and therapeutics at UCD and consultant physician the Mater Misericordiae University Hospital in Dublin in 1996. From 2000 to 2003, he served as UCD's head of the department of medicine. He established new outpatient hemodialysis and peritoneal dialysis units in the Mater Misericordiae University Hospital. He was awarded research grants from the Wellcome Trust, Irish Health Research Board, EU, and industry to build a research group of 40 researchers and support staff. He also led the development of the new UCD McAuley Education and Research Centre on the site of the Mater Misericordiae University Hospital. ==Non-medical career==

President of University College, Dublin (2004–2013) In January 2004, at the age of 44, Brady was appointed president and Chief officer of University College, Dublin (UCD), the youngest in UCD's history. As president, Brady led a programme of change which included: academic restructuring, introduction of the UCD Horizons modular and semesterised undergraduate curriculum, overhaul of UCD's student supports, establishment of the Ad Astra Academy to nurture UCD's highest performing students, establishment of graduate schools and structured PhD programmes to support postgraduate training, creation of a number of thematic multi-disciplinary research institutes, a focus on internationalisation, adoption of innovation as the '3rd pillar' of UCD academic activity, the launch of a new visual identity for UCD, a new campus development plan and capital programme, enhancement of UCD's development and alumni relations functions, and launch of a new fundraising campaign. During his tenure, UCD also introduced independent chairs to UCD's Governing Authority and Finance Committees, and Brady invited the president of UCD's Students Union to join UCD's finance committee. Vice-Chancellor, University of Bristol (2015–2022) In October 2014, it was announced that Brady would become vice-chancellor of the University of Bristol, and in September 2015, he was made vice-chancellor and president of the university, becoming the 13th vice-chancellor. President, Imperial College London (2022-present) Brady was named President of Imperial College London in September 2021, taking up post in August 2022. Other roles Brady has served in a number of external leadership roles, including as a member of the Republic of Ireland's Higher Education Authority, chairman of the Irish Health Research Board, chairman of the Irish Universities Association, president of the Irish Nephrological Society, and chairman of the Universitas 21 global network of global research universities. He also served on the Irish Government's National Innovation Taskforce in 2011 and the oversight committee for Ireland's National Innovation Fund. He is a member of the Public Interest Board of PwC (Ireland) and a non-Executive Director of two multinational companies – Kerry Group plc and ICON plc. He received an Honorary Doctorate of Science from The Queen's University of Belfast, an Honorary Fellowship from the Royal College of Anaesthetists in Ireland and the Robert Menzies Medal from the University of Melbourne. ==Personal==

Brady is married to Professor Yvonne O’Meara, a consultant nephrologist, and they have three sons. ==References==